Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice

Taketoshi Kushida, Yusuke Ueda, Masayuki Umeda, Kenichi Oe, Naofumi Okamoto, Hirokazu Iida, Nader G. Abraham, M. Eric Gershwin, Susumu Ikehara

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The treatment of autoimmune diseases by allogeneic bone marrow transplantation remains a promising therapeutic avenue. However, more intensive studies on murine models are essential before application to a large number of human patients. In particular, the use of bone marrow transplantation to treat rheumatoid arthritis has been problematic. We have taken advantage of the SKG/Jcl mouse that develops a chronic T cell-mediated autoimmune disease that mimics rheumatoid arthritis which attempted to prevent the development of immunopathology in these mice by allogeneic bone marrow transplantation (BMT). In particular, we utilized our unique technology in which bone marrow cells (BMCs) of control C57BL/6J mice are directly injected into the bone marrow cavity in the tibia of SKG mice (intra-bone marrow [IBM]-BMT). As controls, SKG/Jcl mice were transplanted with whole BMCs from syngeneic SKG mice. Importantly, 12 months after IBM-BMT [B6 → SKG] demonstrated no evidence of arthritis, whereas the control [SKG → SKG] mice demonstrated, the expected immunopathology of a rheumatoid arthritis-like condition. Further, hematolymphoid cells in [B6 → SKG] mice were reconstituted by donor-derived cells and the percentages of Treg (Foxp3+/CD4+) cells, the percentages of receptor activator of nuclear factor-κB ligand (RANKL)+ cells on the CD4+T cells and the serum levels of tumor necrosis factor-α, interleukin-1 and interleukin-6 were normalized in the [B6 → SKG] mice. These data suggest that IBM-BMT is a viable method of immunological manipulation that suppresses the severe joint destruction and bone absorption in SKG/Jcl mice and lends further credence to the use of this methodology in humans with intractable rheumatoid arthritis.

Original languageEnglish (US)
Pages (from-to)216-222
Number of pages7
JournalJournal of Autoimmunity
Volume32
Issue number3-4
DOIs
StatePublished - May 2009

Fingerprint

Bone Marrow Transplantation
Rheumatoid Arthritis
Bone Marrow
Bone and Bones
Homologous Transplantation
Bone Marrow Cells
Autoimmune Diseases
T-Lymphocytes
Regulatory T-Lymphocytes
Cytoplasmic and Nuclear Receptors
Tibia
Interleukin-1
Inbred C57BL Mouse
Arthritis
Interleukin-6
Tumor Necrosis Factor-alpha
Joints
Tissue Donors
Ligands
Technology

Keywords

  • Autoimmune disease
  • Bone marrow transplantation
  • SKG/Jcl mouse
  • Stem cell

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Kushida, T., Ueda, Y., Umeda, M., Oe, K., Okamoto, N., Iida, H., ... Ikehara, S. (2009). Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice. Journal of Autoimmunity, 32(3-4), 216-222. https://doi.org/10.1016/j.jaut.2009.02.015

Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice. / Kushida, Taketoshi; Ueda, Yusuke; Umeda, Masayuki; Oe, Kenichi; Okamoto, Naofumi; Iida, Hirokazu; Abraham, Nader G.; Gershwin, M. Eric; Ikehara, Susumu.

In: Journal of Autoimmunity, Vol. 32, No. 3-4, 05.2009, p. 216-222.

Research output: Contribution to journalArticle

Kushida, T, Ueda, Y, Umeda, M, Oe, K, Okamoto, N, Iida, H, Abraham, NG, Gershwin, ME & Ikehara, S 2009, 'Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice', Journal of Autoimmunity, vol. 32, no. 3-4, pp. 216-222. https://doi.org/10.1016/j.jaut.2009.02.015
Kushida, Taketoshi ; Ueda, Yusuke ; Umeda, Masayuki ; Oe, Kenichi ; Okamoto, Naofumi ; Iida, Hirokazu ; Abraham, Nader G. ; Gershwin, M. Eric ; Ikehara, Susumu. / Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice. In: Journal of Autoimmunity. 2009 ; Vol. 32, No. 3-4. pp. 216-222.
@article{88e0f6982f1d4d089143d4518d46dbae,
title = "Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice",
abstract = "The treatment of autoimmune diseases by allogeneic bone marrow transplantation remains a promising therapeutic avenue. However, more intensive studies on murine models are essential before application to a large number of human patients. In particular, the use of bone marrow transplantation to treat rheumatoid arthritis has been problematic. We have taken advantage of the SKG/Jcl mouse that develops a chronic T cell-mediated autoimmune disease that mimics rheumatoid arthritis which attempted to prevent the development of immunopathology in these mice by allogeneic bone marrow transplantation (BMT). In particular, we utilized our unique technology in which bone marrow cells (BMCs) of control C57BL/6J mice are directly injected into the bone marrow cavity in the tibia of SKG mice (intra-bone marrow [IBM]-BMT). As controls, SKG/Jcl mice were transplanted with whole BMCs from syngeneic SKG mice. Importantly, 12 months after IBM-BMT [B6 → SKG] demonstrated no evidence of arthritis, whereas the control [SKG → SKG] mice demonstrated, the expected immunopathology of a rheumatoid arthritis-like condition. Further, hematolymphoid cells in [B6 → SKG] mice were reconstituted by donor-derived cells and the percentages of Treg (Foxp3+/CD4+) cells, the percentages of receptor activator of nuclear factor-κB ligand (RANKL)+ cells on the CD4+T cells and the serum levels of tumor necrosis factor-α, interleukin-1 and interleukin-6 were normalized in the [B6 → SKG] mice. These data suggest that IBM-BMT is a viable method of immunological manipulation that suppresses the severe joint destruction and bone absorption in SKG/Jcl mice and lends further credence to the use of this methodology in humans with intractable rheumatoid arthritis.",
keywords = "Autoimmune disease, Bone marrow transplantation, SKG/Jcl mouse, Stem cell",
author = "Taketoshi Kushida and Yusuke Ueda and Masayuki Umeda and Kenichi Oe and Naofumi Okamoto and Hirokazu Iida and Abraham, {Nader G.} and Gershwin, {M. Eric} and Susumu Ikehara",
year = "2009",
month = "5",
doi = "10.1016/j.jaut.2009.02.015",
language = "English (US)",
volume = "32",
pages = "216--222",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "3-4",

}

TY - JOUR

T1 - Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice

AU - Kushida, Taketoshi

AU - Ueda, Yusuke

AU - Umeda, Masayuki

AU - Oe, Kenichi

AU - Okamoto, Naofumi

AU - Iida, Hirokazu

AU - Abraham, Nader G.

AU - Gershwin, M. Eric

AU - Ikehara, Susumu

PY - 2009/5

Y1 - 2009/5

N2 - The treatment of autoimmune diseases by allogeneic bone marrow transplantation remains a promising therapeutic avenue. However, more intensive studies on murine models are essential before application to a large number of human patients. In particular, the use of bone marrow transplantation to treat rheumatoid arthritis has been problematic. We have taken advantage of the SKG/Jcl mouse that develops a chronic T cell-mediated autoimmune disease that mimics rheumatoid arthritis which attempted to prevent the development of immunopathology in these mice by allogeneic bone marrow transplantation (BMT). In particular, we utilized our unique technology in which bone marrow cells (BMCs) of control C57BL/6J mice are directly injected into the bone marrow cavity in the tibia of SKG mice (intra-bone marrow [IBM]-BMT). As controls, SKG/Jcl mice were transplanted with whole BMCs from syngeneic SKG mice. Importantly, 12 months after IBM-BMT [B6 → SKG] demonstrated no evidence of arthritis, whereas the control [SKG → SKG] mice demonstrated, the expected immunopathology of a rheumatoid arthritis-like condition. Further, hematolymphoid cells in [B6 → SKG] mice were reconstituted by donor-derived cells and the percentages of Treg (Foxp3+/CD4+) cells, the percentages of receptor activator of nuclear factor-κB ligand (RANKL)+ cells on the CD4+T cells and the serum levels of tumor necrosis factor-α, interleukin-1 and interleukin-6 were normalized in the [B6 → SKG] mice. These data suggest that IBM-BMT is a viable method of immunological manipulation that suppresses the severe joint destruction and bone absorption in SKG/Jcl mice and lends further credence to the use of this methodology in humans with intractable rheumatoid arthritis.

AB - The treatment of autoimmune diseases by allogeneic bone marrow transplantation remains a promising therapeutic avenue. However, more intensive studies on murine models are essential before application to a large number of human patients. In particular, the use of bone marrow transplantation to treat rheumatoid arthritis has been problematic. We have taken advantage of the SKG/Jcl mouse that develops a chronic T cell-mediated autoimmune disease that mimics rheumatoid arthritis which attempted to prevent the development of immunopathology in these mice by allogeneic bone marrow transplantation (BMT). In particular, we utilized our unique technology in which bone marrow cells (BMCs) of control C57BL/6J mice are directly injected into the bone marrow cavity in the tibia of SKG mice (intra-bone marrow [IBM]-BMT). As controls, SKG/Jcl mice were transplanted with whole BMCs from syngeneic SKG mice. Importantly, 12 months after IBM-BMT [B6 → SKG] demonstrated no evidence of arthritis, whereas the control [SKG → SKG] mice demonstrated, the expected immunopathology of a rheumatoid arthritis-like condition. Further, hematolymphoid cells in [B6 → SKG] mice were reconstituted by donor-derived cells and the percentages of Treg (Foxp3+/CD4+) cells, the percentages of receptor activator of nuclear factor-κB ligand (RANKL)+ cells on the CD4+T cells and the serum levels of tumor necrosis factor-α, interleukin-1 and interleukin-6 were normalized in the [B6 → SKG] mice. These data suggest that IBM-BMT is a viable method of immunological manipulation that suppresses the severe joint destruction and bone absorption in SKG/Jcl mice and lends further credence to the use of this methodology in humans with intractable rheumatoid arthritis.

KW - Autoimmune disease

KW - Bone marrow transplantation

KW - SKG/Jcl mouse

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=67349206568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349206568&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2009.02.015

DO - 10.1016/j.jaut.2009.02.015

M3 - Article

C2 - 19349145

AN - SCOPUS:67349206568

VL - 32

SP - 216

EP - 222

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 3-4

ER -